AXGN vs LIVN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AXGN · AxoGen$55.75 ▼ 1.06%
LIVN · LivaNova$90.73 ▼ 1.46%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AXGN +96.4%
- LIVN +50.1%
Head to head
| Metric | AXGN | LIVN |
|---|---|---|
| Price | $55.75 | $90.73 |
| Change today | ▼ 1.06% | ▼ 1.46% |
| Market cap | $3.33B | $5.00B |
| Return, 3 months | +13.2% | +15.9% |
| Return, year to date | +70.3% | +47.5% |
| Return, 1 year | +107.5% | +64.1% |
| P/E (TTM) | – | 26.0 |
| P/B | 6.7 | 3.6 |
| P/E percentile vs own 5y | 14th | 75th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +26.2% | +9.9% |
| Net profit growth (YoY) | +229.7% | +28.0% |
| Gross margin | 74.2% | 67.8% |
| Operating margin | -5.2% | 10.7% |
| Net margin | -12.0% | 13.0% |
| Return on equity | -10.3% | 15.5% |
| Analyst target vs. price | +4.4% | +22.7% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 66 | 59 |
| 30-day volatility | 95.1% | 55.2% |
| Max drawdown, 1 year | -33.1% | -18.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LIVN is the largest of the group by market value.
- AXGN has returned the most over the past year.
- AXGN is growing revenue fastest.
- LIVN keeps the most profit per dollar of sales.
- LIVN has been the calmest stock over the last 30 days.